WELLS FARGO & COMPANY/MN - ELEDON PHARMACEUTICALS INC ownership

ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ELEDON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$236
+18.0%
172
+17.8%
0.00%
Q2 2023$200
-1.5%
146
+69.8%
0.00%
Q1 2023$203
+5.7%
86
+2.4%
0.00%
Q4 2022$19284
+2.4%
0.00%
Q3 2022$082
-10.9%
0.00%
Q2 2022$092
+4.5%
0.00%
Q1 2022$0880.0%0.00%
Q4 2021$0
-100.0%
880.0%0.00%
Q3 2021$1,0000.0%88
-4.3%
0.00%
Q2 2021$1,0000.0%92
-1.1%
0.00%
Q1 2021$1,000930.00%
Other shareholders
ELEDON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CM Management, LLC 234,803$321,6800.34%
BVF INC/IL 4,326,710$5,927,5930.16%
ARMISTICE CAPITAL, LLC 1,824,000$2,498,8800.04%
SVB FINANCIAL GROUP 13,472$18,4570.04%
JMAC ENTERPRISES LLC 58,041$79,5160.02%
Woodline Partners LP 603,993$827,4700.01%
INGALLS & SNYDER LLC 51,849$710.00%
Ensign Peak Advisors, Inc 443,001$606,9110.00%
MILLENNIUM MANAGEMENT LLC 27,150$37,1960.00%
Curi RMB Capital, LLC 10,000$13,7000.00%
View complete list of ELEDON PHARMACEUTICALS INC shareholders